Retrospective studies have demonstrated that schizophrenic patients often h
ave poor premorbid cognitive function and social adjustment. Cross-sectiona
l studies of the cognitive performance of schizophrenic patients aged 20 to
90 years indicate that there is a gradual decline in cognitive junction th
roughout the adult life span. Comparison studies of Alzheimer's disease pat
ients, geriatric schizophrenic patients, and normal subjects indicate that
Alzheimer's disease patients have marked impairments in memory and executiv
e function, with impairments in language and constructional ability develop
ing later in the disease. In contrast, schizophrenic patients manifest move
general cognitive impairment with less impairment in memory and move impai
rment in visuospatial and language ability early in the course of dementia.
Neuropathological findings indicate that the dementia associated with schi
zophrenia is pathophysiologically distinct from that of Alzheimer's disease
. Functional impairment in patients with schizophrenia is closely related t
o cognitive deficit but not to positive and negative psychotic symptoms. Ba
sed on these findings, assessment strategies for evaluation of antipsychoti
c drug therapies are proposed to incorporate measures of psychosis, cogniti
on, and function. [Neuropsychopharmacology 21:S203-S210, 1999] (C) 1999 Ame
rican College of: Neuropsychopharmacology. Published by Elsevier Science In
c.